Corporate news | 20.05.2022
Sramek Insight is so pleased to be included in the first batch of HK Tech 300 Angel Fund specializing in bio and health technology,
The first batch of local companies approved for the investment fund, up to HKD 1 Million each under the HK Tech 300 Angel Fund from City University of Hong Kong (CItyU) have been announced on 26th April 2022…
More
Corporate news | 01.02.2023
Sramek Insight was admitted joining the Incu-Bio Programme under the Hong Kong Science Park.
This facilitates the company with network of mentors, strategic partners and investors. With funding support up to HKD 4M financial subsidy and upfront grant HKD 2M to cover regulatory activities like clinical trials…
More
Sramek Insight Limited proudly participated in the HKSTP Startup Boot Camp at Songshan Lake in Dongguan on February 20-21, 2025. Executive Director Mr. Toney Lam presented our upcoming product, Cardiax Home, to potential partners and vendors. The event allowed us to connect with key stakeholders and collaborate with startup founders and mentors for commercialization success.
Sramek Group showcased at CES 2025 in Las Vegas—the premier tech event globally. We unveiled our latest innovation, the Cardiax Home, a cutting-edge cardiovascular monitoring device designed for home use and powered by TEBCO technology. This revolutionary product facilitates early detection of stroke, heart failure, and effective hypertension management.The Cardiax Home captured immense interest from both expo visitors and distributors alike.
See you
there...
Sramek Insight Limited was honored to be selected as one of the representative Park companies to engage in discussions with the delegation. Our Executive Director, Mr. Toney Lam,had the opportunity to communicate directly with the officers from Beijing Medical Insurance Bureau (北京市醫局) , sharing insights and exploring potential areas of cooperation. We look forward to fostering stronger ties and contributing to the advancement of healthcare innovation.
We’ve successfully closed our Seed Round, raising HKD 5 Million, with an overall
valuation on HKD 78 Million.
This investment allows us to accelerate our development and production of the device.
Thanks for incredible support from our investor – Dayton Group
10.10.2024
Sramek Insight is excited to join BIOHK2024 alongside other HKTech 300 teams! We’re eager to showcase our innovative cardiovascular monitoring solutions and demonstrate how we’re transforming healthcare with cutting-edge technology. This event is a fantastic opportunity to connect with industry leaders and explore groundbreaking advancements in the field.
Sramek Insight participated in the Watch Fair held at HKCEC from September 3-7, 2024. We showcased our innovative home-use medical device, Cardiax Home. This non-invasive cardiovascular monitoring device, paired with a blood pressure sensing watch, attracted widespread attention.
09.09.2024
Sramek Insight announces that HOTMAN System prototype (LAB Version) has been granted approval for device registration by National Medical Products Administration of China (“NMPA”). Toney Lam, our Director and Chief Executive Officer commented, “We are very pleased to have achieved this major milestone of our device. The approval will be a strong testament to our research and development for next milestone. It also may shorten the waiting time for commercialization of HOTMAN System (Home Version) – Cardiax.
05.04.2024
Mr. Toney Lam, CEO of Sramek Insight Limited, has been invited as a distinguished speaker in the panel discussion at the 4th IncuBio Open Day, held in collaboration with Amgen. Toney shared his insights on the biotech and hemodynamic screening industries, as well as the importance and possibilities of cardiovascular disease prevention. Following the engaging discussion, Sramek Insight’s showcase booth attracted a flurry of interest from industrial and clinical stakeholders.
22.03.2024
Sramek Insight Limited recently initiated a groundbreaking clinical study in collaboration with Hong Kong Metropolitan University (MU). The study focuses on exploring correlations between biomarkers and cardiovascular disease status using a non-invasive approach. Additionally, researchers aim to uncover potential links between the symbiosis of gut and oral microbiomes and cardiovascular risk factors. This innovative research promises valuable insights for preventive healthcare and improved patient outcomes.
26.02.2024
Sramek Group is proud to announce that we have signed an MOU on 23 January with MAHSA Research and Innovation Sdn. Bhd. and MAHSA University to conduct clinical research on hemodynamic monitoring with drug guidelines by AI. The signing ceremony was attended by Mr. Toney Lam, CEO of Sramek Group, and Professor Dr. Rosnah Binti Mohd Zain, the Deputy Vice-Chancellor of Research and Innovation at MAHSA University, as well as the Chief Executive Officer of MAHSA Research and Innovation Sdn. Bhd..
23.01.2024
Professor Janet Wong and Professor Ronald Pang from Hong Kong Metropolitan University, joined our us as advisors. Their professional experience may help us to facilitate clinical and healthcare research, further increasing the credibility of both sensing and software algorithm.
15.01.2024
Sramek Insight is delighted to have the opportunity to demonstrate our new prototype and device to industry experts, investors, and fellow innovators at BIOHK2023, and we are encouraged by the number of prospective partnerships. We not only gain significant exposure, but we also build relationships….
19.09.2023
During the event, Sramek Insight showcased the company's recent R&D development as well as the progress of our planned home-use medical device. We also had a thorough discussion with China Resources about prospective bio-tech and health-care collaboration and got a lot of interest from….
21.07.2023
Sramek Insight's next products, "Cardiax Home," a home-use cardiovascular analyzer, and "Cardiax Skin," a graphene-based electronic skin for continuous blood flow monitoring, have drawn a large number of visitors and industry insiders for partnership and collaboration discussions.
21.05.2023
InnoEX brings together influential tech experts, entrepreneurs, thought leaders and investors from the region to discuss collaborations, share upcoming trends and exchange insights into future opportunities. Sramek Insight's core technologie provides noninvasive solution for cardiovascular screening.
17.04.2023
Highly sensitive graphene-based material is ideal for collecting cardiovascular data like heart rate, blood pressure as well as blood flow. This helps to reduce the cost of continuous monitoring on heart issues….
20.12.2022
In the Expo, our company is showing the application of hemodynamics at home for remote monitoring cardio-related diseases, and people are highly interested to understand more….
14.12.2022
In June 2022, Sramek Insight signed the Technology Licensing Agreement (TLA) with CityU, for continuous development of the new sensor technology in measuring blood pressure, heart rate and vascular resistance…
06.06.2022
Professor Roy Vellaisamy is expert in Intelligent Devices and Systems (Electronic & Nanoscale Engineering). He will join us to develop new sensors for wearable healthcare product…
01. 06. 2022
Sramek Insight is a company to encourage breakthrough therapies and diagnostic tests, driven by medical AI and to create new methods of prevention and treatment for cardiovascular diseases…
25.11.2021
